NanoGhost Receives an Israel Innovation Authority Grant to Advance Immuno-Oncology Collaboration with BGU
NETANYA, ISRAEL, June 22, 2026 /EINPresswire.com/ -- NanoGhost Ltd., a biotechnology company developing a proprietary targeted drug delivery platform for cancer and other severe diseases, announced today that it has been awarded a new grant from …